Dan Zandberg
Clinical trials sponsored by Dan Zandberg, explained in plain language.
-
Can diabetes drugs boost cancer immunotherapy? new trial aims to find out.
Disease control Recruiting nowThis study tests whether adding metformin or rosiglitazone (drugs used for diabetes) to standard immunotherapy (anti-PD-1) can help shrink tumors or slow cancer growth in people with advanced solid tumors like melanoma, lung cancer, or liver cancer. About 72 participants will be …
Phase: PHASE2 • Sponsor: Dan Zandberg • Aim: Disease control
Last updated Jun 22, 2026 12:03 UTC
-
New drug timing may boost immune attack on head and neck cancer
Disease control Recruiting nowThis study tests a different way of giving chemotherapy along with the immunotherapy drug pembrolizumab for people with head and neck cancer that has come back or spread. The goal is to see if giving chemo in short, strong bursts after the immunotherapy can help the immune system…
Phase: PHASE2 • Sponsor: Dan Zandberg • Aim: Disease control
Last updated Jun 05, 2026 12:05 UTC